Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · IEX Real-Time Price · USD
99.76
+0.80 (0.81%)
At close: Jul 19, 2024, 4:00 PM
99.77
+0.01 (0.01%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Ligand Pharmaceuticals Revenue

Ligand Pharmaceuticals had revenue of $118.31M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $30.98M. In the year 2023, Ligand Pharmaceuticals had annual revenue of $131.31M.

Revenue (ttm)
$118.31M
Revenue Growth
-41.92%
P/S Ratio
15.15
Revenue / Employee
$2,039,879
Employees
58
Market Cap
1.79B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023131.31M-64.93M-33.09%
Dec 31, 2022196.25M-45.30M-18.75%
Dec 31, 2021241.54M77.98M47.68%
Dec 31, 2020163.56M43.28M35.98%
Dec 31, 2019120.28M-131.17M-52.17%
Dec 31, 2018251.45M110.35M78.21%
Dec 31, 2017141.10M32.13M29.48%
Dec 31, 2016108.97M37.06M51.53%
Dec 31, 201571.91M7.38M11.43%
Dec 31, 201464.54M15.57M31.78%
Dec 31, 201348.97M17.59M56.02%
Dec 31, 201231.39M1.35M4.50%
Dec 31, 201130.04M6.50M27.61%
Dec 31, 201023.54M-15.40M-39.55%
Dec 31, 200938.94M11.63M42.56%
Dec 31, 200827.32M14.42M111.84%
Dec 31, 200712.89M8.92M224.21%
Dec 31, 20063.98M-6.24M-61.07%
Dec 31, 200510.22M-101.90M-90.89%
Dec 31, 2004112.11M30.99M38.21%
Dec 31, 200381.12M9.35M13.03%
Dec 31, 200271.77M-4.57M-5.99%
Dec 31, 200176.34M28.23M58.68%
Dec 31, 200048.11M7.22M17.64%
Dec 31, 199940.90M23.22M131.40%
Dec 31, 199817.67M-34.03M-65.82%
Dec 31, 199751.70M14.86M40.33%
Dec 31, 199636.84M12.33M50.28%
Dec 31, 199524.52M11.21M84.21%
Dec 31, 199413.31M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Harmony Biosciences Holdings 617.51M
Veracyte 375.47M
Zai Lab 291.07M
RxSight 101.10M
Keros Therapeutics 234.00K
Revenue Rankings